Advisors Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Advisors Management Group's BMY Position: Q1 2026 in Review
Advisors Management Group reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q1 2026, selling an estimated $84.9K and leaving 5,650 shares worth $342K. The position accounts for 0.06% of the portfolio, ranked #127.
Advisors Management Group first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $493K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Advisors Management Group held 5,650 shares of Bristol-Myers Squibb worth $342K as of Q1 2026.
- Advisors Management Group sold 1,457 Bristol-Myers Squibb shares in Q1 2026, an estimated $84.9K.
- Bristol-Myers Squibb made up 0.06% of Advisors Management Group's portfolio in Q1 2026, its #127 holding.
- Advisors Management Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
- Advisors Management Group's Bristol-Myers Squibb position peaked at $493K in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.